Search
Showing results for "8"
We rely on our fundraisers enormously. Not only are they out there raising money to help fund our research into children’s health, they’re raising awareness within the community about the broad scope of work we do. They are helping to create hope for children and their families. Want to get involved?
Head, Early Neurodevelopment & Mental Health; Healthway WA Senior Research Fellow
Perth’s The Kids Research Institute Australia has praised the Food Safety Ministers of Australia and New Zealand for standing firm and putting children first by approving the recommended red, black and white mandatory warning label on alcohol products.
The Wesfarmers Centre of Vaccines and Infectious Diseases has appointed Mrs Valerie Swift to a newly created Aboriginal Cultural Guidance Advisor position.
Join Dr Andrew Whitehouse, head of Developmental Disorders research at The Kids, as he shares with you his vision for autism research.
Perth researchers have begun a trial to test the effectiveness in children and seniors of a new vaccine to protect against the potentially deadly bird flu.
Pregnancy and the postnatal period can be a time of increased psychological distress, which can be detrimental to both the mother and the developing child. Digital interventions are cost-effective and accessible tools to support positive mental health in women during the perinatal period.
The social and emotional wellbeing of Aboriginal children and young people
The understanding of children's social and emotional development in middle childhood is critical to promote well-being throughout the life course. Children who fail to develop social and emotional competencies are more likely to experience difficulties in adulthood and, in the worst case, psychopathology. The current study will employ Cross-Lagged Network Models to investigate children's social and emotional development among Australian children aged 6 to 10 years.
High-grade gliomas including glioblastoma (GBM) and diffuse midline gliomas (DMG) represent the most lethal and aggressive brain cancers where current treatment modalities offer limited efficacy. Chimeric antigen receptor (CAR) T cell therapies have emerged as a promising strategy, boasting tumor-specific targeting and the unique ability to penetrate the blood-brain barrier.